Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Santen Pharmaceutical is a leading Japanese pharmaceutical company specializing in ophthalmology. It researches, develops, manufactures, and distributes innovative medications and therapies to improve eye health globally. The company is dedicated to patients with eye diseases and to promoting vision.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Santen Pharmaceutical is scheduled to report its next quarterly earnings on 11/05/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Santen Pharmaceutical last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at 22.38 JPY.
Across its last 5 earnings reports, Santen Pharmaceutical stock moved by ±1.9% on average the following day. The largest reaction was -3.7% on 05/12/2026; 2 of 5 reactions were positive.
Santen Pharmaceutical has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 5 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.